Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy

Daniel E. Hilleman; E. C. Wadibia; B. Shinn

Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy

Daniel E. Hilleman, E. C. Wadibia, B. Shinn

Department of Pharmacy Practice

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,

Original language	English (US)
Pages (from-to)	36S
Journal	Chest
Volume	110
Issue number	4 SUPPL.
State	Published - Oct 1 1996

All Science Journal Classification (ASJC) codes

Pulmonary and Respiratory Medicine
Critical Care and Intensive Care Medicine
Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy'. Together they form a unique fingerprint.

Cite this

@article{0725d5c06ca44983a58747895b0281d7,

title = "Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy",

abstract = "Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV, ",

author = "Hilleman, {Daniel E.} and Wadibia, {E. C.} and B. Shinn",

year = "1996",

month = oct,

day = "1",

language = "English (US)",

volume = "110",

pages = "36S",

journal = "Chest",

issn = "0012-3692",

publisher = "American College of Chest Physicians",

number = "4 SUPPL.",

}

TY - JOUR

T1 - Pharmacoeconomic evaluation of COPD

T2 - Stratification of outcomes and costs according to initial drug therapy

AU - Hilleman, Daniel E.

AU - Wadibia, E. C.

AU - Shinn, B.

PY - 1996/10/1

Y1 - 1996/10/1

N2 - Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,

AB - Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,

UR - http://www.scopus.com/inward/record.url?scp=33746398668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746398668&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33746398668

VL - 110

SP - 36S

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4 SUPPL.

ER -

Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Cite this